| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |